PP01.04: Targeting the YTHDF3-AGO2 Axis: A Novel Strategy to Overcome Osimertinib Resistance in Lung Adenocarcinoma
Fields of Study & Subjects
RNA modifications and cancer
Lung Cancer Treatments and Mutations
Chromatin Remodeling and Cancer
Publication details
- Journal / source
- Journal of Thoracic Oncology
- Volume
- 21
- Issue
- 1
- Pages
- S40–S40
- Publication date
- 1 January 2026
- Language
- EN